Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2613-2025Class I

Reprocessed ViewFlex Xtra ICE Catheter to visualize cardiac structures; blood flow and other devices within...

MEDLINE INDUSTRIES, LP - Northfield / initiated 2025-07-31 / Open, Classified

Medline Industries, LP began a recall of Reprocessed ViewFlex Xtra ICE Catheter to visualize cardiac structures; blood flow and other devices within the heart. Medline Item Numbers D087031RH on . FDA classified it as Class I and gives the reason as "Specific lots of reprocessed electrophysiology and ultrasound catheters may contain small residual particulates. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk...". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2613-2025
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Product
Reprocessed ViewFlex Xtra ICE Catheter to visualize cardiac structures; blood flow and other devices within the heart. Medline Item Numbers D087031RH
Product code
OWQ Reprocessed Intravascular Ultrasound Catheter
Reason for recall
Specific lots of reprocessed electrophysiology and ultrasound catheters may contain small residual particulates. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk of an inflammatory response or systemic infection, and if particulate were to dislodge during use and contact circulating blood and/or the heart, it may produce a granulomatous reaction or thrombus formation, which may lead to cerebral or pulmonary embolism, or deep vein thrombosis.
FDA root cause
Under Investigation by firm
Action
On July 31, 2025, the firm notified customers via first class mail and email of the potential product issue. An updated letter was sent to customers on 8/13/25 with additional item and lot numbers. Affected products are to be returned for credit. Customers were instructed to immediately identify and quarantine all affected product within their possession. Once they have completed and returned the response form listing their affected inventory, they will receive return labels and RGA information. Customers will receive credit when the returned product is received.
Quantity in commerce
7913 eaches
Distribution
Domestic US distribution nationwide. International distribution pending. No international distribution.
Product codes and lots
Item Number/UDI-DI D087031RH 10197344019557 LOTS EP240731 EP240814 EP240826 EP240903 EP240916 EP241003 EP241014 EP241028 EP241104 EP241112 EP241202 EP241209A EP241219 EP241224 EP250114 EP250116 EP250204 EP250219

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2613-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2610-2025Class IOngoingVoluntary: Firm initiated
Z-2611-2025Class IOngoingVoluntary: Firm initiated
Z-2612-2025Class IOngoingVoluntary: Firm initiated
Z-2613-2025Class IOngoingVoluntary: Firm initiated
Z-2614-2025Class IOngoingVoluntary: Firm initiated